GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Runben Biotechnology Co Ltd (SHSE:603193) » Definitions » Ending Cash Position

Runben Biotechnology Co (SHSE:603193) Ending Cash Position : ¥62 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Runben Biotechnology Co Ending Cash Position?

Runben Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥62 Mil.

Runben Biotechnology Co's quarterly Ending Cash Position declined from Sep. 2024 (¥129 Mil) to Dec. 2024 (¥107 Mil) and declined from Dec. 2024 (¥107 Mil) to Mar. 2025 (¥62 Mil).

Runben Biotechnology Co's annual Ending Cash Position declined from Dec. 2022 (¥368 Mil) to Dec. 2023 (¥284 Mil) and declined from Dec. 2023 (¥284 Mil) to Dec. 2024 (¥107 Mil).

Runben Biotechnology Co Ending Cash Position Historical Data

The historical data trend for Runben Biotechnology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Runben Biotechnology Co Ending Cash Position Chart

Runben Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 39.53 202.67 368.15 283.83 106.59

Runben Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.74 259.18 129.41 106.59 62.38

Runben Biotechnology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Runben Biotechnology Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=283.825+-177.236
=107

Runben Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=106.589+-44.213
=62

Runben Biotechnology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Runben Biotechnology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Runben Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Runben Biotechnology Co Ltd (SHSE:603193) » Definitions » Ending Cash Position
Comparable Companies
SHSE:603868 SHSE:600315 SZSE:003006 SZSE:301371 SZSE:300957 SHSE:603983 SZSE:002511 SHSE:605009 SZSE:001328 SHSE:603630 PG XPAR:OR LSE:ULVR CL BOM:500696 KMB KVUE LSE:RKT XTER:HEN3 XTER:BEI
Traded in Other Exchanges
N/A
Address
No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangdong, Guangzhou, CHN, 510627
Website
https://www.runben.com
Runben Biotechnology Co Ltd is engaged in research & development, production and sales of mosquito repellent and personal care products.

Runben Biotechnology Co Headlines

No Headlines